Jorge Nieva

@nievamd

Oncologist, scientist, teacher & learner

Vrijeme pridruživanja: svibanj 2016.

Tweetovi

Blokirali ste korisnika/cu @nievamd

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @nievamd

  1. proslijedio/la je Tweet
    2. pro 2019.
    Poništi
  2. proslijedio/la je Tweet
    7. stu 2019.
    Poništi
  3. proslijedio/la je Tweet

    Watch this special Lung Cancer Awareness Month message from former NFL linebacker & national lung cancer spokesperson on why prevention is not enough in the fight against lung cancer. Early detection & research matters!

    Poništi
  4. proslijedio/la je Tweet
    17. lis 2019.
    Poništi
  5. proslijedio/la je Tweet
    13. lis 2019.
    , , i još njih 4
    Poništi
  6. proslijedio/la je Tweet
    27. tra 2019.
    Poništi
  7. proslijedio/la je Tweet

    Stephen V. Liu, MD, is an associate professor of medicine and the senior researcher on a new analysis of a new gene fusion believed to be responsible for development of a wide spectrum of cancer types: cc:

    Poništi
  8. proslijedio/la je Tweet

    We are proud of our visionary collaboration with and from of how to digitize clinical performance at and .

    Poništi
  9. proslijedio/la je Tweet
    31. ožu 2019.

    Here is our review of frailty assessment in the pre-HSCT setting with detailing objective methods of assessment.

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet

    It is the season! Check out our lineup for and don't miss and as Opening Plenary speakers! Our representing at this year's

    Poništi
  11. proslijedio/la je Tweet
    31. ožu 2019.

    & : fascinating talk by a physician & a physicist re:digitizing cancer & the cancer patient to improve outcomes. Quantifying connection betwwwb ECOG & tx success could lead to better tx matches & clinical trial participation

    Poništi
  12. proslijedio/la je Tweet
    31. ožu 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Same % in France ... and all patients have access to Cancer Care

    Poništi
  13. proslijedio/la je Tweet
    31. ožu 2019.

    Fantastic tag team talk by & , a physicist & an MD, on digitizing clin assessment for evidence-based prediction of outcomes. Encourage all to watch the archived webcast when avail. My takeaway: when we venture outside of our own silos, science wins.

    Poništi
  14. proslijedio/la je Tweet

    "In 20 years we've gone from having one line of therapy for lung cancer, compared to four or five lines today," says in today's first plenary - CaA

    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    31. ožu 2019.

    This tag team Plenary- Physicist vs. Physician is making my day

    Poništi
  16. proslijedio/la je Tweet
    31. ožu 2019.

    Kicking off my day 2 at with opening plenary from and on a prognostic factor that those of us in the lab might not consider: how well can a patient get from a chair onto the exam table? Unbiased ECOG PS measurement might help address cancer disparities

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    31. ožu 2019.

    First up: Dr. Peter Kuhn and Dr. Jorge J. Nieva present “Physicist vs. physician: Digitizing clinical assessment and using it for evidence-based prediction of outcomes.”

    Poništi
  18. 29. ožu 2019.

    A great series of presentations for AACR 2019

    Poništi
  19. 1. velj 2019.
    Poništi
  20. 16. sij 2019.

    Certain patients need to be careful with the use of these exciting new agents. Tuberculosis following PD-1 blockade for cancer immunotherapy

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·